Cardinal to buy J&J vascular technology unit Cordis for $1.9 bln
March 02, 2015 at 07:48 AM EST
NEW YORK, March 2 (Reuters) - Cardinal Health said on Monday that it would buy Johnson & Johnson's Cordis vascular technology unit for $1.9 billion and that the acquisition would boost 2017 earnings by 20 cents per share.
